Analysis of embryo intactness and developmental potential following slow freezing and vitrification

Size: px
Start display at page:

Download "Analysis of embryo intactness and developmental potential following slow freezing and vitrification"

Transcription

1 Systems Biology in Reproductive Medicine ISSN: (Print) (Online) Journal homepage: Analysis of embryo intactness and developmental potential following slow freezing and vitrification Lan Yu, Chanwei Jia, Yonglian Lan, Rui Song, Liying Zhou, Ying Li, Yu Liang & Shuyu Wang To cite this article: Lan Yu, Chanwei Jia, Yonglian Lan, Rui Song, Liying Zhou, Ying Li, Yu Liang & Shuyu Wang (2017) Analysis of embryo intactness and developmental potential following slow freezing and vitrification, Systems Biology in Reproductive Medicine, 63:5, , DOI: / To link to this article: Published online: 10 Aug Submit your article to this journal Article views: 12 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at Download by: [ ] Date: 06 September 2017, At: 05:00

2 SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE 2017, VOL. 63, NO. 5, RESEARCH COMMUNICATION Analysis of embryo intactness and developmental potential following slow freezing and vitrification Lan Yu, Chanwei Jia, Yonglian Lan, Rui Song, Liying Zhou, Ying Li, Yu Liang, and Shuyu Wang Department of Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China ABSTRACT The aim of this study was to identify the parameters that are related to intactness and developmental potential of a day 3 embryo after warming to improve the selection criteria used to cryopreserve and transfer embryos. We also sought to compare slow freezing and vitrification methods of cryopreservation and to evaluate the viability of non-intact embryos. Embryos warmed following slow freezing (n=220) or vitrification (n=522) were divided into 3 groups according to the proportion of surviving blastomeres (I<50%; II=50-99%; and III=100%). The developmental potential of embryos, including the mitosis resumption rate, blastocyst formation rate, and formation rate of grade A blastocysts (i.e., fully expanded blastocysts with an inner cell mass and grade A or B trophectoderm) were retrospectively assessed in embryos. Cleavage-stage embryos with <50% blastomere survival were analyzed using next-generation sequencing (NGS). Logistic regression analysis showed that vitrification and grade 1 were independent predictive factors of embryo intactness and developmental potential (all p<0.05). On day 3, embryos with 4-6 cells or blastomere damage had lower developmental potential than those with 7-9 cells or intact blastomeres (all p<0.05). NGS results showed that the chromosomal status was completely normal in 8 embryos that developed into expanded blastocysts, whereas 4 out of 5 embryos in which development was arrested were abnormal. The results of this study suggest that vitrification is a better choice than slow freezing for embryo cryopreservation. Embryos showing poor quality (fragmentation >30% and/or a non-stage-specific cell size) and lower cell numbers (4-6 cells) on day 3 should be cultured to the blastocyst stage and then vitrified if they develop into goodquality blastocysts. The developmental potential of non-intact embryos is lower than that of intact embryos; however, after they are cultured to the fully expanded blastocyst stage, embryos with <50% blastomere survival appear to be better candidates for transfer. Abbreviations ART: assisted reproductive technology; grade A blastocyst: fully expanded blastocyst with an inner cell mass and grade A or B trophectoderm; NGS: next-generation sequencing; IVF: in vitro fertilization; ICSI: intracytoplasmic sperm injection; FET: frozen-thawed embryo transfer Introduction Cryopreservation has become an integral part of assisted reproductive technology (ART) [He et al. 2016]. Most reports regarding the developmental potential of embryos after warming have involved the slow-freezing method. The developmental potential of cryopreserved cleavagestage embryos treated with slow freezing has been investigated, and higher blastocyst formation rates and implantation rates have been obtained using fully intact embryos than when using damaged day 2 embryos [El-Toukhy et al. 2003; Archer et al. 2003]. One study suggested that pregnancy and implantation rates were lower when the blastomere lysis rate in day 3 embryos was greater than 25% but not greater than 50%, [Tang et al. 2006]. However, another study reported that the developmental potential of partially damaged frozen and thawed ARTICLE HISTORY Received 2 February 2017 Revised 8 July 2017 Accepted 10 July 2017 KEYWORDS Blastocyst culture; cryopreservation; embryo; next-generation sequencing; non-intact embryo embryos might be equivalent to that of fully survived embryos [Rienzi et al. 2005]. Previous studies have shown that during slow freezing, the presence of one or two lysed blastomeres in a thawed day 3 embryo did not appear to have a negative influence on the further development of sibling intact cells [Rienzi et al. 2005]. In recent years, vitrification has progressively replaced slow freezing in in vitro fertilization (IVF) laboratories [Fernandez Gallardo et al. 2016; Guanetal.2016; VanLanduytetal. 2013]. One study indicated that the overnight cleavage rate in day 3 embryos is lower in damaged than in fully intact embryos after both vitrification and slow freezing [Van Landuyt et al. 2013]. However, few reports have compared development to the blastocyst stage between CONTACT Shuyu Wang yushu572000@126.com Department of Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Road 251, Chaoyang, Beijing , China Taylor & Francis

3 286 L. YU ET AL. intact and non-intact embryos that were submitted to vitrification and slow freezing. Generally, during frozen embryo transfer (FET), an embryo possessing >50% viable blastomeres following warming is considered a survivor [Gardner et al. 2012] and is therefore transferred. While most studies have focused on embryos with % viable cells after warming, in our study, the embryos were distributed into groups with blastomere survival rates of <50% and 50%-99% after warming, and the embryos were then cultured to determine their developmental potential. Cells in cleavage-stage embryos are totipotent [Van de Velde et al. 2000]. So even if a part of the embryo is lost, the cleavage-stage embryo remains capable of producing an intact individual. However, few previous reports have evaluated the viability of such embryos. We analyzed these embryos using next-generation sequencing (NGS), which is a large-scale, high-throughput, and massive paired-end mapping method that can be used to detect structural variations in genomes [Liang et al. 2017]. The Gardner grading system [Gardner et al. 2012] is capable of effectively predicting clinical outcomes regarding implantation, clinical pregnancy, and live birth [Richardson et al. 2015]; blastocysts with an expansion grade of 4, 5, or 6 (i.e., fully expanded), an inner cell mass, and grade A or B trophectoderm (i.e., a grade A blastocyst) are associated with better clinical outcomes. To determine the influence of blastomere loss on the developmental potential of cryopreserved cleavage-stageembryos,wecompared the effects of blastomere loss in embryos that were subjected to slow freezing and vitrification on day 3 and subsequently cultured. We evaluated the development potential (i.e., mitosis resumption, blastocyst formation, and grade A blastocyst formation) of embryos with different degrees of damage (i.e., I: <50%, II: 50-99%, and III: intact survival), different grades (i.e., 1-3 based on cell size and fragmentation), and different cell numbers before freezing. Furthermore, to evaluate viability, blastocysts that developed from embryos with a blastomere survival rate <50% were sequenced and analyzed using NGS. Results A total of 742 cryopreserved-warmed embryos were used in this study; they were cultured to days 5-6 to determine whether they could develop into expanded blastocysts. These included embryos with a blastomere survival rate <50% (5.4%, group I, n=40), 50-99% blastomere survival (23.0%, group II, n=171), and intact survival (71.6%, group III, n=531). Results from multivariate logistic analysis of the factors associated with the cell survival rate (I: <50%; II: 50-99%; and III: 100%) are shown in Table 1. Age (30.1 ± 3.9, 30.6 ± 3.7, and 30.4 ± 3.9 years old, respectively) and the IVF (vs. ICSI) rate (80.0%, 84.8%, and 81.2%, respectively) were not independently associated with intactness (p>0.05). Grade 1 was an independent protective factor that was more associated with the maintenance of intactness of embryos than grade 3 (I vs. III, odds ratio 0.32, 95% confidence interval ; and II vs. III, odds ratio 0.38, 95% confidence interval ). Cell number was negatively associated with the cell survival rate (p>0.05), and the vitrification cryopreservation method (p<0.05) was positively associated with intactness (Table 1). Among the embryos included in this analysis (n=742), 29.6% (n=220) were subjected to the slow freezing method, and 70.4% (n=522) were subjected to the vitrification method. There was no significant difference in the average age between the slow freezing (32.6±4.2) and the vitrification (31.1±3.9) groups Table 1. Multivariate logistic regression analysis of different cell survival rates. I(n=40) II (n=171) III (n=531) OR (95% CI) I vs. III OR (95% CI) II vs. III Age (y) 30.1 ± ± ± ( ) 1.03( ) IVF 32(80.0) 145(84.8) 430(81.2) 0.98( ) 1.33( ) ICSI 8(20.0) 26(16.2) 101(18.8) ref ref Grade 1 9(22.5) 43(25.1) 217(40.9) *0.32( ) *0.38( ) Grade 2 21(52.5) 88(51.5) 238(44.8) 0.67( ) 0.70( ) Grade 3 10(25.0) 40(23.4) 76(14.3) ref ref Cell number 1 8(20.0) 53(31.0) 170(32.0) 0.73( ) 1.13( ) Cell number 2 28(70.0) 100(58.5) 288(54.2) 1.83( ) 1.45( ) Cell number 3 4(10.0) 18(10.5) 73(13.7) ref ref Slow freezing 23(57.5) 86(50.3) 111(20.9) *5.84( ) *4.11( ) vitrification 17(42.5) 85(49.7) 420(79.1) ref Ref Proportion of surviving blastomeres: group I (<50%), group II (50%-99%), and group III (100%); Grade 1: fragmentation <10% and a stage-specific cell size; grade 2: fragmentation 10-30% with/without a stage-specific cell size for the majority of cells; grade 3: fragmentation 30-50% with/without a non-stagespecific cell size; Cell number: 1: cell number between 4-6; cell number 2: cell number between 7-9; and cell number 3: cell number greater than 9. Data are presented as n (%); *P<0.05.

4 SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE 287 (p>0.05). The survival rate (89.5%, 197/220 vs. 96.7%, 505/522; odds ratio 0.29, 95% confidence interval ) and the rate of intactness (50.5%, 111/220 vs. 80.7%; 421/522, OR 0.24, 95% confidence interval ) were significantly lower in the slow-freezing group than in the vitrification group (p<0.05). Similarly, the mitosis resumption rate (odds ratio 0.61, 95% confidence interval ), the blastocyst formation rate (odds ratio 0.60, 95% confidence interval ), and the grade A blastocyst formation rate (odds ratio 0.59, 95% confidence interval ) were significantly lower in the slow-freezing group than in the vitrification group (p<0.05, Table 2). Logistic regression analysis showed that the cryopreservation procedure used on embryos (i.e., slow freezing or vitrification) and grade of embryo had independent effects (all p<0.05, Table 3) but not an interactive effect on the rates of mitosis resumption, blastocyst formation, and grade A blastocyst formation (all p>0.05, Table 2). In contrast, the cryopreservation procedure and intactness of the embryos had an interactive effect on the developmental potential, as did the cryopreservation procedure and cell number of embryos (all p<0.05, Table 3). In the group of intact embryos (group III), logistic regression analysis showed that the cryopreservation procedure (slow freezing or vitrification) had no independent effect on the rates of mitosis resumption (odds ratio 1.49, 95% confidence interval ) and grade A blastocyst formation (odds ratio 1.36, 95% confidence interval ) (all p>0.05). In contrast, the cryopreservation procedure had an independent effect on the rate of blastocyst formation (odds ratio 1.58, 95% confidence interval , p<0.05). In the 7-9-cell group, logistic regression analysis showed that the cryopreservation procedure (slow freezing or vitrification) had no independent effect on the rates of mitosis resumption (odds ratio 0.22, 95% confidence interval ), blastocyst formation (odds ratio 0.25, 95% confidence interval ), and grade A blastocyst formation (odds ratio 1.32, 95% confidence interval ) (all p>0.05). Grade 2 embryos had significantly lower rates of mitosis resumption (251/347, 72.3%, odds ratio 0.66, 95% confidence interval ), blastocyst formation (202/347, 58.2%, odds ratio 0.61, 95% confidence interval ), and grade A blastocyst formation (133/347, 38.3%, odds ratio 0.61, 95% confidence interval ) than grade 1 embryos (215/269, 79.9%; 187/269, 69.5%; and 136/269, 50.6% in rate of mitosis resumption, blastocyst formation, and grade A blastocyst formation, respectively). The intact embryo rates were not significantly different among embryos with 4-6 cells, 7-9 cells, and >9 Table 2. Developmental potential of different grades of embryos. Method Slow freezing (n=220) Vitrification (n=522) OR (95% CI) Grade (n,%) 1(71, 32.3) 2(121, 55.0) 3(28, 12.7) 1(198, 37.9) 2(226, 43.3) 3(98, 18.8) Survival % 65(91.5) 107(88.4) 25(89.3) 195(98.5) 219(96.9) 91(92.9) 0.53( ) Intact % 37(52.1) 58(47.9) 16(57.1) 180(90.9) 181(80.1) 60(61.2) 0.39( )* Mitosis resumption % 51(71.8) 80(66.1) 15(53.6) 335(79.0) 171(75.7) 60(61.2) 0.83( ) Blastocyst formation % 42(59.2) 62(51.2) 8(28.6) 145(73.2) 140(61.9) 38(38.8) 0.85( ) Grade A blastocysts % 29(40.8) 38(31.4) 2(7.1) 107(54.0) 95(42.0) 19(19.4) 1.02( ) OR: interactions between cryopreservation method and different graded embryos. Data are presented as n (%), *p<0.05. Table 3. Logistic regression analysis of development. Mitosis resumption % Blastocyst formation % Grade A blastocyst % OR (95% CI) OR (95% CI) OR (95% CI) I vs. III 0.18( )* 0.22( )* 0.07( )* II vs. III 0.65( )* 0.60( )* 0.51( )* II vs. I 3.61( )* 2.73( )* 7.85( )* Cell 2 vs ( )* 2.21( )* 3.00( )* Cell 3 vs ( ) 1.59( ) 2.09( )* Cell 2 vs ( )* 1.39( ) 1.44( ) Grade 2 vs ( )* 0.61( )* 0.61( )* Grade 3 vs ( )* 0.25( )* 0.20( )* Grade 2 vs ( )* 2.42( )* 3.11( )* Slow freezing vs. vitrification 0.61( )* 0.60( )* 0.59( )* Interaction ( )* 1.23( )* 1.27( )* Interaction ( )* 1.25( )* 1.29( )* Interaction 1: interactions between the cryopreservation method and the intactness of the embryo; Interaction 2: interactions between the cryopreservation method and the cell number of the embryo. Data are presented as n (%); *p<0.05.

5 288 L. YU ET AL. cells (p>0.05). Logistic regression analysis showed that the mitosis resumption (154/231, 66.7% vs. 324/416, 77.9%), blastocyst formation (107/231, 46.3% vs. 273/ 416, 65.6%), and grade A blastocyst formation rates (54/231, 23.4% vs. 199/416, 47.8%) were significantly lower in embryos with 4-6 cells (54/231, 23.4%) than in those with 7-9 cells (37/95, 38.9%; all p<0.05). The grade A blastocyst formation rate was significantly lower in embryos with 4-6 cells than in those with >9 cells (odds ratio 2.04, 95% confidence interval , p<0.05). Among the different blastomere survival groups, logistic regression analysis showed that embryos in group II had a significantly higher mitosis resumption rate (117/171, 68.4%), rate of blastocyst formation (87/171, 50.9%), and grade A blastocyst formation rate (50/171, 29.2%) than those in group I (15/40, 37.5%; 11/40, 27.5%; and 2/40, 5.0% rate of mitosis resumption, blastocyst formation, and grade A blastocyst formation, respectively; all p<0.05), whereas these rates were significantly lower in group II than in group III (409/531, 77.0%; 337/ 531, 63.5%; and 238/531, 44.8% rate of mitosis resumption, blastocyst formation and grade A blastocyst formation, respectively; all p<0.05, Table 3). Thenumberofembryoswithablastomeresurvival rate <50% was so small that for this group, our study also included embryos that were cryopreserved on day 2 and day 3. Thirteen cleavage-stage embryos with a blastomere survival rate <50% were analyzed using NGS, and all were donated. Seven embryos were subjected to slow freezing, and 6 were subjected to vitrification. Seven embryos were evaluated after freezing/thawing. Of these, 2 developed arrest (2/7, 28.6%) and exhibited aneuploidy (2/2, 100%), and 5 (5/7, 71.4%) were normal (5/5,100%) expanded blastocysts. Six were evaluated after being vitrified/ warmed. Of these, 3 developed arrest (3/6, 50.0%), 2 of those exhibited aneuploidy (2/3, 66.7%), and 3 (3/ 6, 50.0%) were normal (3/3, 100%) expanded blastocysts (Tables 4 and 5). The results showed that the chromosomal status was normal in all 8 (8/8) embryos that developed into fully expanded blastocysts, whereas most (4/5) of the Table 4. NGS of cleavage stage embryos with <50% blastomere survival between those with developmental arrest and expanded blastocysts. Developed arrest (n=5) Expanded blastocyst (n=8) Variable Slow freezing Vitrification Slow freezing Vitrification No. embryos Normal % 0(0) 1(33.3) 5(100.0) 3(100.0) Data are presented as n (%). Table 5. Chromosomal status of embryos with <50% blastomere survival. Embryonic stage on Day Method a Before b After b biopsy day Interpretation 3 S cell Complex abnormal 3 S cell 47,XX,+15 3 S 7 3 5BC 46,XY 2 S 4 1 5BA 46,XY 2 S 5 1 6BA 46,XX 2 S 4 1 4CB 46,XY 2 S 4 1 6BA 46,XX 3 V 8 4 5BB 46,XX 2 V 4 1 4CC 46,XX 2 V 4 1 4BC 46,XY 3 V cell 45,XX,-22,del(1p p34.3),dup(5p p15.1) 3 V cell 46,XX 2 V cell 48,XY,+4,+X a Cryopreservation method: S-slow freezing and V-vitrification; b cell number: before (after) cryopreservation. embryos that underwent developmental arrest had an abnormal chromosomal status (Tables 4 and 5). Discussion In this study, we aimed to identify the parameters that are related to day 3 embryo intactness and developmental potential after warming to improve the selection criteria used to cryopreserve and transfer embryos. We also sought to compare the slow freezing and vitrification methods of cryopreservation and evaluate the viability of non-intact embryos. Our results showed that the embryo grade had an independent effect on embryo intactness. Grade 1 (i.e., <10% fragmentation and a stage-specific cell size) was an independent protective factor that was more closely associated with the maintenance of intactness in embryos than grade 3 (30-50% fragmentation and/or a non-stage-specific cell size); however, grade 3 embryos had lower blastocyst and grade A blastocyst formation rates than grade 1 and 2 embryos. Consistent with these findings, a recent study suggested that embryos with 10-25% fragmentation and/or symmetry <75% should be cryopreserved because they display acceptable implantation potential [Fernandez Gallardo et al. 2016]. It has therefore been recommended that embryos with high developmental potential should be identified using morphological criteria, including <30% fragmentation and a stage-specific cell size on day 3. Using these criteria avoids the need for costly treatments that have low success rates. We also compared embryonic intactness and developmental potential after both vitrification and slow freezing. Logistic regression analysis showed that

6 SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE 289 vitrification had a positive independent effect on intactness, the mitosis resumption rate, the blastocyst formation rate, and the grade A blastocyst rate of embryos (all p<0.05) compared to slow freezing. Our results show that the cryopreservation method and embryo grade did not have interactive effects on the mitosis resumption, blastocyst formation, and grade A blastocyst formation rates, but the cryopreservation method and intactness of the embryo had interactive effects on those parameters, as did the cryopreservation method and cell number (all p<0.05). We also found that in the 7-9-cell group (cell number 2 group) and the intact embryo group (group III) there were no statistically significant differences in the rates of mitosis resumption and grade A blastocyst formation between the slow freezing and vitrification groups (p>0.05). These findings indicated that slow developing cleavage-stage embryos had lower developmental potential. Vitrification preserved cell intactness better than slow freezing. Previous reports have shown that in mouse embryos, slow freezing is more likely to induce chromatin damage than is vitrification [Martino et al. 2013; Somoskoi et al. 2015]. A consensus is slowly emerging regarding the notion that better embryological and clinical outcomes are obtained following the use of vitrification procedures than following the use of slow freezing procedures [De Munck et al. 2013]. Our results show that the intactness rate did not differ significantly among embryos with 4-6 cells, 7-9 cells, and >9 cells, but the rates of mitosis resumption, blastocyst formation, and grade A blastocyst formation were significantly lower in embryos with 4-6 cells than in those with 7-9 cells (p<0.05). The grade A blastocyst formation rate was significantly lower in embryos with 4-6 cells than in those with >9 cells. In partial agreement with these results, other reports have shown that on day 3, the continued development rate [Van Landuyt et al. 2013] and the blastocyst formation rate were higher in embryos with 7-9 cells than in embryos with more than 9 or fewer than 7 cells [Alikani et al. 2000]. Another study showed that having too few cells decreased embryonic development [Stylianou et al. 2012]. In addition, studies have shown that having a high number of cells (>9 cells) on the third day results in the formation of more desirable, high-quality blastocysts (i.e., 4AA or better) [Luna et al. 2008] and that the developmental potential, implantation rate, and live birth rate of day 3 embryos increased with cell number [Kong et al. 2016]. Finally, another report showed that embryos with <5 cells had little developmental potential [Yang et al. 2015]. We analyzed the developmental potential of intact and non-intact embryos after warming. Among groups III, II, and I, we found that the mitosis resumption, blastocyst formation, and grade A blastocyst formation rates were all significantly decreased by this process (all p<0.05). Similar to the findings reported in our study, a previous study showed that blastomere loss following slow freezing impaired preimplantation development and resulted in reduced cell numbers at the periimplantation stages [Archer et al. 2003]. Early reports indicated that partially intact embryos had lower implantation rates because of the toxic influence of the damaged blastomeres on sibling cells and embryos [Rienzi et al. 2002]. Recent studies have shown that there was no difference in the live birth rate between embryos with partial loss of blastomeres (i.e., 1 blastomere in day 2 embryos or 1 or 2 blastomeres in day 3 embryos) following FET cycles. Additionally, the live births were achieved using only good-quality cryopreserved intact embryos (<20% fragmentation and 4-5 blastomeres at day 2 or 7-9 blastomeres at day 3) [DuPont et al. 2015]. According to the current standards for FET, embryos with >50% blastomere loss are not regarded as surviving embryos and should therefore be discarded. In our study, the developmental potential was lower in embryos with <50% surviving blastomeres than in intact embryos. A previous study showed that vitrified and slowly frozen embryos have similar implantation potentials if further cleavage occurs overnight, regardless of the number of cells lost [Van Landuyt et al. 2013]. The NGS results in the present study showed that the chromosomal status was normal in 8 embryos with <50% blastomere survival that were cultured into fully expanded blastocysts, whereas most developmentally arrested embryos (4/5) had chromosomal abnormalities. These results suggest that cleavagestage embryos with <50% blastomere survival could be considered for transfer after they are cultured to fully expanded blastocysts. To our knowledge, our study is the first to use NGS to investigate the chromosomal status of embryos with lower than 50% blastomere survival. Embryos that failed to reach the blastocyst stage were more likely to have poor developmental potential; if these embryos were transferred at the cleavage stage, they would be destined to fail to implant [Zhu et al. 2013]. We found that after freezing and subsequent thawing, 28.6% of embryos experienced developmental arrest, and all of those embryos exhibited aneuploidy; the other 71.4% became fully expanded blastocysts, and all of those embryos were normal. Following vitrification and warming, 50.0% of the embryos experienced developmental arrest, and 66.7% of those embryos exhibited aneuploidy; the other 50.0% became fully expanded blastocysts, and those embryos

7 290 L. YU ET AL. were all normal. Embryos in which fewer than 50% of the blastomeres survived following slow freezing had a higher developmental potential than those subjected to vitrification. This suggests that there were reasons other than aneuploidy for embryonic arrest following vitrification. However, additional studies with a larger sample size are required to verify these findings, and additional studies [Carbone and Chavez 2015 ] investigating the genetic, epigenetic, and chromosomal characteristics of non-intact embryos should be performed. It is crucial to select embryos with the highest implantation potential for transfer [Yin et al. 2016]. Cleavagestage embryos with poor survival that develop into good quality blastocysts should also be transferred. Blastulation depends not only on the survival and mitosis resumption of the embryo (the cryopreservation technique) but also on the capacity of the embryo to develop. Culturing the embryo provides enough time for the embryo to show its potential and has therefore become a valuable tool during embryo selection [Martins et al. 2016]. Increasing the standards used in choosing frozen cleavage-stage embryos will improve outcomes and avoid the need for costly treatments with low success rates [Veleva et al. 2013]. One study showed that slow development (<5 cells on day 3) and fragmentation (>15%) interfered with the formation of apparently normal blastocysts [Alikani et al. 2000]. Therefore, day 3 embryos with 4-6 cells [Balaban et al. 2011] or poor quality embryos should be cultured to the blastocyst stage and vitrified if they develop into good-quality blastocysts [Shaw-Jackson et al. 2013]. It has been observed in the case of vitrification that although embryos are often intact, they do not always resume mitosis within 24 hours. Certain embryos do, nevertheless, implant and lead to healthy births. Extended culture will help in the identification of such embryos. Directly extending fresh embryos to the blastocyst stage prior cryopreservation could be considered. This allows the selection of embryos with implantation potential; survival is less of an issue since the blastocyst has many cells, and embryo selection can be performed in a few hours based on re-expansion. In our study, in vitro observation scores were used to evaluate the relationships among blastomere loss, embryo grade, and development potential. Further studies are required to determine the rates of implantation and live births following embryo transfer. We have demonstrated that vitrification is the better choice for embryo cryopreservation because it results in superior outcomes compared with those obtained with slow freezing. Embryo grades could be used to more effectively select embryos with low fragmentation (<30%) and a stage-specific cell size containing more than 6 cells to be cryopreserved on day 3. Poor-quality embryos and those with low cell numbers on day 3 should be cultured to the blastocyst stage and vitrified if they develop into good-quality blastocysts. After warming, the developmental potential of non-intact embryos is lower than that of intact embryos. However, in our study, NGS showed that most of the embryos in which fewer than 50% of the blastomeres survived appeared normal if they were allowed to develop into fully expanded blastocysts, at which point transfer could be considered. However, additional studies are needed to evaluate the possibility of using embryos with less than 50% blastomere survival in a clinical setting. Materials and methods This study was approved by the Ethics Committee of Beijing Obstetrics and Gynecology Hospital of Capital Medical University. The patient samples used in this study were obtained with informed consent. Study design This was a retrospective, observational study that was conducted in the Department of Reproductive Medicine of the Beijing Obstetrics and Gynecology Hospital (Beijing, China). Analyses of day 3 cryopreserved embryos that were warmed and developed to days 5-6 were performed between August 2013 and January The day 3 embryos were cryopreserved by either slow freezing (n=216) or vitrification (n=522). After they were warmed, the embryos were separated into the following 3 groups based on the proportion of surviving blastomeres: group I (<50%), group II (50-99%), and group III (100%). The embryos were further cultured to determine their developmental potential; blastocyst formation rates and whether they became grade A blastocysts were evaluated. Thirteen embryos in which blastomere survival was <50% were analyzed using NGS. In this study, we evaluated standard morphological characteristics (e.g., the number of blastomeres, symmetry, and fragmentation) before the embryos were cryopreserved at day 3. After they were warmed, all embryos in this study were cultured to day 5 or 6. The embryos that were transferred developed into blastocysts; analyses were performed on those that developed into expanded blastocysts on day 5 or were transferred on day 6. We investigated the intactness, survival, mitosis resumption rate, blastocyst formation rate, and the grade A blastocyst formation rate of day 3 vitrified/warmed and slow frozen/thawed embryos.

8 SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE 291 Ovarian stimulation and in vitro culture Patients underwent controlled ovarian hyperstimulation using a long GnRH-a protocol or a GnRH-ant protocol. In the long GnRH-a protocol, a down-regulation protocol that combined a gonadotrophin-releasing hormone agonist with recombinant human follicle-stimulating hormone (FSH) was followed by individual dose adjustment, as required, according to the patient s ovarian response. In the GnRH-ant protocol, cetrorelix was injected at a dose of 0.25 mg daily when the leading follicle was 12 to 13 mm in diameter. Treatment was continued until the day human chorionic gonadotrophin (hcg) was injected. Ovulation was triggered by injecting 250 µg of recombinant hcg when the two leading follicles had a mean diameter of 17 mm or wider. Ultrasound-guided transvaginal oocyte retrieval was performed h later. Oocytes were inseminated using either conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) according to routine protocols [Gardner et al. 2012]. Fertilization was considered normal when two pronuclei were present between 16 and 18 h after insemination. In this study, only normally fertilized oocytes were further considered for embryo cryopreservation. All zygotes were cultured in cleavage medium (Sydney IVF, COOK, Brisbane, Australia) covered in oil in a 37 C incubator (C200, Labortect, Gottingen, Germany) with a 6% CO 2,5%O 2, and 89% N 2 atmosphere until day 3 after insemination. Classification of cryopreserved embryos Embryonic development was assessed prior to cryopreservation. Embryo quality was assessed using the manual scoring system of the Department of Reproductive Medicine at the Beijing Obstetrics and Gynecology Hospital of Capital Medical University. This system was based on a visual evaluation of the number and size of blastomeres [Balaban et al. 2011] and the degree of fragmentation. Grade 1 referred to embryos with <10% fragmentation and a stage-specific cell size. It is generally accepted that for embryos at the 4- and 8-cell stages, the blastomeres should be evenly sized. For all other cell stages, one would expect size differences among the cells [Balaban et al. 2011]. Grade 2 referred to embryos with 10-30% fragmentation with or without a stage-specific cell size for the majority of cells. Grade 3 referred to embryos with 30-50% fragmentation with or without a non-stage-specific cell size. Only embryos that were graded 1-3 were included in the study. Cryopreservation and warming protocols Slow freezing Day 3 embryos were sequentially dehydrated in Embryo Freezing Medium (Cook Scientific, Brisbane, Australia) and loaded into a 0.25 ml plastic straw (IMV, France). They were then frozen in a programmable freezer (Planer Products Ltd., UK). The temperature was decreased to -7 C at a rate of 2 C/min from room temperature. Seeding was performed manually at -7 C by touching a straw close to the cotton plug using forceps that were cooled in liquid nitrogen. Then, the embryos were further cooled to -32 C at a rate of -0.3 C/min, cooled to -140 C at a rate of -50 C/min, and then plunged into liquid nitrogen tanks for storage. To thaw the embryos, straws containing slow-cooled day 3 embryos were removed from liquid nitrogen and held in the air at room temperature for 30 s. They were then immersed in a 30 C water-bath for s until the ice melted. Cryoprotectants were removed using sequential dilutions in Embryo Thawing Medium (Cook Scientific). Vitrification procedure The vitrification and warming procedure was conducted according to the protocol recommended in the Kitazato Vitrification Kit. All materials required for vitrification were obtained from Kitazato (Tokyo, Japan). The embryos were equilibrated for 5-15 min at room temperature in equilibration solution until the volume of cells was completely recovered. They were then placed in vitrification solution for s. One or two embryos were picked up into the tip of a transfer pipette using a minimal volume of vitrification solution (0.1 μl or less) and then placed on a Cryotop strip. Within 30 s of suspending the cells in the vitrification medium, the strip with the embryos was plunged into liquid nitrogen. After they were warmed, the embryos were immediately immersed in a 37 C warming solution for 1 min. They were then recovered and rehydrated using a 3-step dilution protocol at room temperature. After the cells were warmed and diluted, they were transferred to blastocyst media for culture. Evaluation of the intactness of embryos after warming After the embryos were warmed, the intactness of the embryos was determined by quantifying the proportion of morphologically intact cells in the embryo. Embryos were considered intact when all of the blastomeres had

9 292 L. YU ET AL. well-defined membranes and cytoplasm with no sign of lysis or degeneration. Morphological survival after warming was expressed as the percentage of warmed embryos that remained fully intact or in which at least 50% of the cells were intact. In our study, embryos were incubated for an additional 3 days to assess blastulation potential. The embryos were subsequently cultured in blastocyst medium (Sydney IVF, COOK) covered with oil in a 37 C incubator (Labortect, C200) with a 6% CO 2,5% O 2, and 89% N 2 atmosphere to the blastocyst stage. Blastocysts were given a numeric score from 1 6 based on the degree of expansion and hatching status. Richardson et al. [2015] noted that when using the Gardner grading system [Gardner et al. 2012], blastocysts that had an expansion grade of 4, 5, or 6 (i.e., were fully expanded), an inner cell mass, and a grade A or B trophectoderm had the highest implantation rate. This grading scheme can be used to effectively predict clinical outcomes including implantation, clinical pregnancy, and live birth. In this study, we called such blastocysts grade A blastocysts. Next-generation sequencing (NGS) Donated cleavage-stage embryos with <50% blastomere survival were cultured to day 5-7 and used to perform NGS. The zona pellucida was separated from whole cells that were obtained from embryos or blastocysts. Template DNA was generated using standard degenerate oligonucleotide primer PCR (DOP-PCR), and the resulting products were sequenced using Illumina sequencing at BGI-Shenzhen. The series procedure [Zhang et al. 2013] and quality controls were all performed by BGI-Shenzhen. Theoretically, all CNVs larger than 1 megabase were detected. Statistical analysis The Statistical Package for Social Sciences (SPSS: version 21.0, IBM, Chicago, USA) was used for all statistical analyses. Descriptive data are presented as the mean ± SD (standard deviation), and variance in the measured data was analyzed using ANOVA. Categorical variables are expressed as percentages. The rate was calculated using the chi-square test, and interactions between fixed factors were calculated using logistic regression analysis. P values <0.05 were considered statistically significant. Declaration of interests This work was supported in part by grants from the Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201510) and the Beijing Municipal Science and Technology Commission (code: Z ). The authors report no conflicts of interest. Notes on contributors Conceived and designed the experiments: SW; Performed the experiments: LY, RS, LZ; Analyzed the data: LY, CJ; Contributed reagents/materials/analytical tools: YLan, YLi, YLiang; Wrote the manuscript: LY, CJ. All authors approved all revisions and the final paper. ORCID Lan Yu References Alikani, M., Calderon, G., Tomkin, G., Garrisi, J., Kokot, M. and Cohen, J. (2000) Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod 15: Archer, J., Gook, D.A. and Edgar, D.H. (2003) Blastocyst formation and cell numbers in human frozen-thawed embryos following extended culture. Hum Reprod 18: Balaban, B., Brison, D., Calderón, G., Catt, J., Conaghan, J., Cowan, L., et al. (Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology) (2011) The Istanbul consensus workshop on embryo assessment: Proceedings of an expert meeting. Hum Reprod 26: Carbone, L. and Chavez, S.L. (2015) Mammalian pre-implantation chromosomal instability: species comparison, evolutionary considerations, and pathological correlations. Syst Biol Reprod Med 61: De Munck, N., Verheyen, G., Van Landuyt, L., Stoop, D. and Van de Velde, H. (2013) Survival and post-warming in vitro competence of human oocytes after high security closed system vitrification. J Assist Reprod Genet 30: Dupont, C., Hafhouf, E., Sermondade, N., Sellam, O., Herbemont, C., Boujenah, J., et al. (2015) Delivery rates after elective single cryopreserved embryo transfer related to embryo survival. Eur J Obstet Gynecol Reprod Biol 188:6 11. El-Toukhy, T., Khalaf, Y., Al-Darazi, K., Andritsos, V., Andritsos, V., Taylor, A., et al. (2003) Effect of blastomere loss on the outcome of frozen embryo replacement cycles. Fertil Steril 79: Fernandez Gallardo, E., Spiessens, C., D Hooghe, T. and Debrock, S. (2016) Effect of embryo morphology and morphometrics on implantation of vitrified day 3 embryos after warming: a retrospective cohort study. Reprod Biol Endocrinol 14:40. Gardner, D.K., Weissman, A., Howles, C.M. and Shoham, Z. (2012) Textbook of Assisted Reproductive Techniques, Laboratory and Clinical Perspectives, Third Edition, Informa Healthcare, UK.

10 SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE 293 Guan, Y., Fan, H., Styer, A.K., Xiao, Z., Li, Z., Zhang, J., et al. (2016) A modified natural cycle results in higher live birth rate in vitrified-thawed embryo transfer for women with regular menstruation. Syst Biol Reprod Med 62: He, Q.H., Wang, L., Liang, L.L., Zhang, H.L., Zhang, C.L., Li, H.S., et al. (2016) Clinical outcomes of frozen-thawed single blastocyst transfer in patients requiring whole embryo freezing. Syst Biol Reprod Med 62: Kong, X.,Yang, S., Gong, F., Lu, C., Zhang, S., Lu, G., et al. (2016) The relationship between cell number, division behavior and developmental potential of cleavage stage human embryos: A Time-Lapse study. Plos One 11: e Liang, D., Wang, Y., Ji, X., Hu, H., Zhang, J., Meng, L., et al. (2017) Clinical application of whole-genome low-coverage next-generation sequencing to detect and characterize balanced chromosomal translocations. Clin Genet 91: Luna, M., Copperman, A.B., Duke, M., Ezcurra, D., Sandler, B. and Barritt, J. (2008) Human blastocyst morphological quality is significantly improved in embryos classified as fast on day 3 (>or=10 cells), bringing into question current embryological dogma. Fertil Steril 89: Martino, N.A., Dell Aquila, M.E., Cardone, R.A., Somoskoi, B., Lacalandra, G. M. and Cseh, S. (2013)Vitrification preserves chromatin integrity, bioenergy potential and oxidative parameters in mouse embryos. Reprod Biol Endocrinol 11:27. Martins, W.P., Nastri, C.O., Rienzi, L., van der Poel, S.Z., Gracia, C.R. and Racowsky, C. (2016) Obstetrical and perinatal outcomes following blastocyst transfer compared to cleavage transfer: a systematic review and meta-analysis. Hum Reprod 31: Richardson, A., Brearley, S., Ahitan, S., Chamberlain, S., Davey, T., Zujovic, L., et al. (2015) A clinically useful simplified blastocyst grading system. Reprod Biomed Online 31: Rienzi, L., Nagy, Z.P., Ubaldi, F., Lacobelli, M., Anniballo, R., Tesarik, J., et al. (2002) Laser-assisted removal of necrotic blastomeres from cryopreserved embryos that were partially damaged. Fertil Steril 6: Rienzi, L., Ubaldi, F., Iacobelli, M., Minasi, M.G., Romano, S., Ferrero, S., et al. (2005) Developmental potential of fully intact and partially damaged cryopreserved embryos after laser-assisted removal of necrotic blastomeres and postthaw culture selection. Fertil Steril 84: Shaw-Jackson, C., Bertrand, E., Becker, B., Colin, J., Beaudoin-Chabot, C., Rozenberg, S., et al. (2013) Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming. J Assist Reprod Genet 30: Somoskoi, B., Martino, N.A., Cardone, R.A., Lacalandra, G. M., Dell Aquila, M.E. and Cseh, S. (2015) Different chromatin and energy/redox responses of mouse morulae and blastocysts to slow freezing and vitrification. Reprod Biol Endocrinol 13:22. Stylianou, C., Critchlow, D., Brison, D.R. and Roberts, S.A. (2012) Embryo morphology as a predictor of IVF success: An evaluation of the proposed UK ACE grading scheme for cleavage stage embryos. Hum Fertil 15: Tang, R., Catt, J. and Howlett, D. (2006) Towards defining parameters for a successful single embryo transfer in frozen cycles. Hum Reprod 21: Van de Velde, H., De Vos, A., Serman, K., Staessen, C., De Rycke, M., Van Assche, E., et al. (2000) Embryo implantation after biopsy of one or two cells from cleavage-stage embryos with a view to preimplantation genetic diagnosis. Prenat Diagn 20: Van Landuyt, L., Van de Velde, H., De Vos, A., Haentjens, P., Blockeel, C., Tournaye, H., et al. (2013) Influence of cell loss after vitrification or slow-freezing on further in vitro development and implantation of human Day 3 embryos. Hum Reprod 28: Veleva, Z., Orava, M., Nuojua-Huttunen, S., Tapanainen, J.S. and Martikainen, H. (2013) Factors affecting the outcome of frozen-thawed embryo transfer. Hum Reprod 28: Yang, S.T., Shi, J.X., Gong, F., Zhang, S.P., Lu, C.F., Tan, K., et al. (2015) Cleavage pattern predicts developmental potential of day 3 human embryos produced by IVF. Reprod Biomed Online 30: Yin, B.L., Hao, H.Y., Zhang, Y.N., Wei, D. and Zhang, C.L. (2016) Good quality blastocyst from non-/mono-pronuclear zygote may be used for transfer during IVF. Syst Biol Reprod Med 62: Zhang, C.L., Zhang, C.S., Chen, S.P., Yin, X.Y., Pan, X.Y., Lin, G., et al. (2013) A single cell level based method for copy number variation analysis by low coverage massively parallel sequencing. Plos One 8:e Zhu, L., Xi, Q., Zhang, H., Li, Y., Ai, J. and Jin, L. (2013) Blastocyst culture and cryopreservation to optimize clinical outcomes of warming cycles. Reprod Biomed Online 27:

Case report: Pregnancy After Vitrification of Biopsied Human Blastocysts Previously Frozen by the Slow Method

Case report: Pregnancy After Vitrification of Biopsied Human Blastocysts Previously Frozen by the Slow Method Case report: Pregnancy After Vitrification of Biopsied Human Blastocysts Previously Frozen by the Slow Method Batwala, M., Wilding, M., Create Fertility, Cheapside, London, UK Dalapati, T., University

More information

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their

More information

Cleavage Stage Embryo Cryopreservation Slow Freezing Versus Vitrification

Cleavage Stage Embryo Cryopreservation Slow Freezing Versus Vitrification Cleavage Stage Embryo Cryopreservation Slow Freezing Versus Vitrification Basak Balaban VKF American Hospital of Istanbul Assisted Reproduction Unit Head of IVF Laboratory Turkish Society of Clinical Embryologists

More information

Preimplantation genetic diagnosis: polar body and embryo biopsy

Preimplantation genetic diagnosis: polar body and embryo biopsy Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director

More information

Abstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 15 December 2003

Abstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online;   on web 15 December 2003 RBMOnline - Vol 8. No 2. 207-211 Reproductive BioMedicine Online; www.rbmonline.com/article/1023 on web 15 December 2003 Article Determining the most optimal stage for embryo cryopreservation Anthony Anderson

More information

Patient selection criteria for blastocyst culture in IVF/ICSI treatment

Patient selection criteria for blastocyst culture in IVF/ICSI treatment J Assist Reprod Genet (2010) 27:555 560 DOI 10.1007/s10815-010-9457-9 ASSISTED REPRODUCTION Patient selection criteria for blastocyst culture in IVF/ICSI treatment M. Y. Thum & V. Wells & H. Abdalla Received:

More information

Abstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online; on web 21 August 2009

Abstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online;   on web 21 August 2009 RBMOnline - Vol 19. No 4. 2009 521 525 Reproductive BioMedicine Online; www.rbmonline.com/article/4153 on web 21 August 2009 Article Increasing dehydration of human cleavagestage embryos prior to slow

More information

The 5th World congress of the INTERNATIONAL SOCIETY FOR FERTILITY PRESERVATION Vienna, Austria November 16-18, 2017

The 5th World congress of the INTERNATIONAL SOCIETY FOR FERTILITY PRESERVATION Vienna, Austria November 16-18, 2017 Vitrification: "Robots" versus Human Comparing automated vitrification outcomes The 5th World congress of the INTERNATIONAL SOCIETY FOR FERTILITY PRESERVATION Vienna, Austria November 16-18, 2017 Zsolt

More information

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Andrea Weghofer Foundation for Reproductive Medicine 2017 New York, November 16-19 Conflict of interest No relevant financial

More information

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

Chromosomal Aneuploidy

Chromosomal Aneuploidy The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common

More information

Extended embryo culture in human assisted reproduction treatments

Extended embryo culture in human assisted reproduction treatments Human Reproduction Vol.16, No.5 pp. 902 908, 2001 Extended embryo culture in human assisted reproduction treatments M.T.Langley 1,3, D.M.Marek 1, D.K.Gardner 2, K.M.Doody 1 and K.J.Doody 1 1 Center for

More information

IVF: PAST, PRESENT AND FUTURE

IVF: PAST, PRESENT AND FUTURE IVF: PAST, PRESENT AND FUTURE Mark Larman Chief Scientific Officer 1 HISTORY OF IVF IVF first achieved with rabbits in 1959 IVF with human gametes - pioneered by Robert Edwards and Patrick Steptoe during

More information

Patrick Quinn IVF PROTOKOL FOR SINGLE EMBRYO CULTURE

Patrick Quinn IVF PROTOKOL FOR SINGLE EMBRYO CULTURE 1. With cumulus-free oocytes and embryos up to Day (D) 3, use 275-300 um diameter pipette tips to minimize medium transfer between drops; transfer volume should be < 1 ul. DAY -1 2. At ~ 4.00 pm on the

More information

Tammie Roy Genea Biomedx Sydney, Australia. Declared to be stakeholder in Genea Biomedx

Tammie Roy Genea Biomedx Sydney, Australia. Declared to be stakeholder in Genea Biomedx Tammie Roy Genea Biomedx Sydney, Australia Declared to be stakeholder in Genea Biomedx 1 24-25 September 2015 Madrid and Alicante, Spain Importance of cryopreservation in Assisted Reproductive Technology

More information

Cryopreservation of human oocytes with slow freezing techniques

Cryopreservation of human oocytes with slow freezing techniques ESHRE Campus Symposium Cryobiology and cryopreservation of human gametes and embryos Athens, Greece 25-26 September 2009 Cryopreservation of human oocytes with slow freezing techniques Giovanni Coticchio

More information

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent PGT analysis is offered to patients that seek to identify a chromosomal abnormality in their embryos prior to initiating

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,

More information

Vitrification: "Robots" versus Human Comparing automated vitrification outcomes

Vitrification: Robots versus Human Comparing automated vitrification outcomes Vitrification: "Robots" versus Human Comparing automated vitrification outcomes The 5th World congress of the INTERNATIONAL SOCIETY FOR FERTILITY PRESERVATION Vienna, Austria November 16-18, 2017 Zsolt

More information

Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos

Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos J. Mamm. Ova Res. Vol. 31 (1), 40 44, 2014 40 Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos Yamato Mizobe*, Toshiaki Akiyoshi, Shiho Minami, Kan Matsuo,

More information

Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY

Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:

More information

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Study on Several Factors Involved in IVF-ET of Human Beings

Study on Several Factors Involved in IVF-ET of Human Beings Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,

More information

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management Dr Guy Gudex Director Repromed 17:00-17:30 Recent Advances in Fertility Management Recent Advances in Fertility Management Practice Nurses Programme NZMA GP CME June 2018 Dr Guy Gudex ART in NZ -2014 ACART

More information

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Aila Tiitinen Professor, reproductive medicine Head of IVF unit Helsinki University The outline

More information

The Viability Of Human Embryos After Transport In A Dry Shipper Between Assisted Conception Laboratories

The Viability Of Human Embryos After Transport In A Dry Shipper Between Assisted Conception Laboratories Article ID: WMC001104 2046-1690 The Viability Of Human Embryos After Transport In A Dry Shipper Between Assisted Conception Laboratories Corresponding Author: Ms. Clare Pinkus, Scientist, Hollywood Fertility

More information

VITRIFICATION CRYOTOP

VITRIFICATION CRYOTOP VITRIFICATION CRYOTOP KITAZATO VITRIFICATION THE CRYOTOP METHOD Kitazato is recognized as one of the pioneering brands in driving and improving vitrification. Its greatest contribution in this field has

More information

Page 1 of 5 Egg Freezing Informed Consent Form version 2018 Main Line Fertility Center. Egg Freezing. Informed Consent Form

Page 1 of 5 Egg Freezing Informed Consent Form version 2018 Main Line Fertility Center. Egg Freezing. Informed Consent Form Page 1 of 5 Egg Freezing Informed Consent Form version 2018 Egg Freezing Informed Consent Form Embryos and sperm have been frozen and thawed with good results for many years. Egg (oocyte) freezing is a

More information

Slow freezing of mouse embryos Slow freezing of domestic animal embryos Slow freezing of human embryos 1972 1973/74 1983 Slow freezing of human embryos Slow freezing of human oocytes 1985 1989 1993 1996

More information

Cryotop Vitrification Affects Oocyte Quality and Embryo Developmental Potential

Cryotop Vitrification Affects Oocyte Quality and Embryo Developmental Potential Cronicon OPEN ACCESS Ling Jia*, Bo Xu*, Yu-sheng Liu and Xian-hong Tong Center for Reproductive Medicine, Anhui Provincial Hospital Affiliated to Anhui Medical University, China *These authors contributed

More information

Article Examination of frozen cycles with replacement of a single thawed blastocyst

Article Examination of frozen cycles with replacement of a single thawed blastocyst RBMOnline - Vol 11. No 3. 2005 349-354 Reproductive BioMedicine Online; www.rbmonline.com/article/1679 on web 5 July 2005 Article Examination of frozen cycles with replacement of a single thawed blastocyst

More information

SHORT COMMUNICATION SEOUL, SOUTH KOREA

SHORT COMMUNICATION SEOUL, SOUTH KOREA ( C 2006) DOI: 10.1007/s10815-005-9006-0 SHORT COMMUNICATION SEOUL, SOUTH KOREA Optimization of a Dilution Method for Human Expanded Blastocysts Vitrified Using EM Grids After Artificial Shrinkage Submitted

More information

Vitrification of reproductive cells: The next breakthrough in ART? Department of Obstetrics and Gynaecology University of Aberdeen

Vitrification of reproductive cells: The next breakthrough in ART? Department of Obstetrics and Gynaecology University of Aberdeen Vitrification of reproductive cells: The next breakthrough in ART? Maureen J Wood PhD Department of Obstetrics and Gynaecology University of Aberdeen breakthrough Some signal achievement in scientific

More information

Medicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study

Medicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study Observational Study Medicine Combined analysis of endometrial thickness and pattern in predicting clinical outcomes of frozen embryo transfer cycles with morphological good-quality blastocyst A retrospective

More information

Hold On To Your Dreams

Hold On To Your Dreams Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create

More information

FRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018

FRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018 FRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018 OBJECTIVES Hisory Indication of freezing embryos Slow freezing versus vitrification Advantages

More information

Female Patient Name: Social Security # Male Patient Name: Social Security #

Female Patient Name: Social Security # Male Patient Name: Social Security # Female Patient Name: Social Security # Male Patient Name: Social Security # THE CENTER FOR HUMAN REPRODUCTION (CHR) ILLINOIS/NEW YORK CITY * ASSISTED REPRODUCTIVE TECHNOLOGIES PROGRAM (A.R.T.) CRYOPRESERVATION

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

RapiDVIT & rapidwarm oocyte. Specialised media for oocyte vitrification.

RapiDVIT & rapidwarm oocyte. Specialised media for oocyte vitrification. RapiDVIT & rapidwarm oocyte Specialised media for oocyte vitrification. Special media for A unique cell Cryopreservation of oocytes requires care. Some preservation techniques cause premature oocyte activation

More information

Article Outcome of blastocyst transfer according to availability of excess blastocysts suitable for cryopreservation

Article Outcome of blastocyst transfer according to availability of excess blastocysts suitable for cryopreservation RBMOnline - Vol 7. No 5. 587 592 Reproductive BioMedicine Online; www.rbmonline.com/article/1010 on web 10 October 2003 Article Outcome of blastocyst transfer according to availability of excess blastocysts

More information

Problem Challenge Need. Solution Innovation Invention

Problem Challenge Need. Solution Innovation Invention Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978

More information

OVERVIEW AND FACTS: CRYOPRESERVATION

OVERVIEW AND FACTS: CRYOPRESERVATION OVERVIEW AND FACTS: CRYOPRESERVATION Imprint Published in August, 2013 By Victory A.R.T. Laboratory Phils, Inc. This ebook was created by http://www.ivfvictoryphilippines.com/ in hopes of helping bring

More information

Vitrification of day 3 cleavage-stage embryos yields better clinical outcome in comparison with vitrification of day 2 cleavage-stage embryos

Vitrification of day 3 cleavage-stage embryos yields better clinical outcome in comparison with vitrification of day 2 cleavage-stage embryos Zygote 23 (April), pp. 169 176. C Cambridge University Press 2013. The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike

More information

2013 Sep.; 24(3):

2013 Sep.; 24(3): Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0151 2013 Sep.; 24(3):151-158 E-mail: randc_journal@163.com Reducing the Trigger Dose of Human Chorionic Gonadotrophin Does

More information

CRYOTOP SAFETY KIT Protocol. Cryotop Method

CRYOTOP SAFETY KIT Protocol. Cryotop Method CRYOTOP SAFETY KIT Protocol Cryotop Method R Vitrification PART Materials Required Cryotop Safety Kit-Vitrification No.0 Basic Solution (BS): 1 X 1.5ml vial (Only for Oocyte Vitrification) No.1 Equilibration

More information

Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?

Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Human Reproduction Vol.19, No.11 pp. 2550 2554, 2004 Advance Access publication August 6, 2004 doi:10.1093/humrep/deh447 Should we advise patients undergoing IVF to start a cycle leading to a day 3 or

More information

I.C.E. Embryo Vitrification Kit

I.C.E. Embryo Vitrification Kit I.C.E. Embryo Vitrification Kit Vitrification Media V1, V2, V3 ICE Embryo Vitrification Instructions For Use Testing and Cautions Innvative Cryo Enterprises LLC 317 Springfield Road Linden, New Jersey

More information

Rapid- Vitrification System. Closed system for simple and successful vitrification.

Rapid- Vitrification System. Closed system for simple and successful vitrification. Rapid- Vitrification System Closed system for simple and successful vitrification. 3 working together for you Media Method Device & accessories Rapid-i Vitrification System puts you in control. The method,

More information

Proper steps for bull semen dilution and freezing. IMV Technologies France

Proper steps for bull semen dilution and freezing. IMV Technologies France Proper steps for bull semen dilution and freezing IMV Technologies France Introduction Since Polge reported the first successful cryopreservation of spermatozoa in 1949, spermatozoa from many mammalian

More information

Non-invasive methods of embryo selection

Non-invasive methods of embryo selection Non-invasive methods of embryo selection Liow Swee Lian O & G Partners Fertility Centre Gleneagles Hospital SINGAPORE Introduction More physiological laboratory procedures and culture systems have significantly

More information

Thinning and drilling laser-assisted hatching in thawed embryo transfer: A randomized controlled trial

Thinning and drilling laser-assisted hatching in thawed embryo transfer: A randomized controlled trial ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2018;45(3):129-134 Thinning and drilling laser-assisted hatching in thawed embryo transfer: A randomized controlled trial Minh Tam Le

More information

UvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication

UvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication UvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication Citation for published version (APA): Mastenbroek, S. (2011). Preimplantation

More information

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology Thrombosis during assisted reproduction Scott Nelson Muirhead Chair in Obstetrics & Gynaecology ART can be as safe as natural pregnancy!! What used to be the risk of thrombosis in ART!! We can use AMH

More information

Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS

Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University

More information

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology Minimising IVF related mortality and morbidity Scott Nelson Muirhead Professor in Obstetrics & Gynaecology We rarely say no - so what I will cover today VTE as an example of a modifiable IVF complication

More information

The Impact of ESHRE 2017 on Japanese Fertility Practice

The Impact of ESHRE 2017 on Japanese Fertility Practice The Impact of ESHRE 2017 on Japanese Fertility Practice This resource is supported by an educational grant from Merck KGaA, Darmstadt, Germany. The GWHA was interested in the opinions of practicing clinicians

More information

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 IVF-THE ULTIMATE GOAL FERTILISATION EMBRYO CLEAVAGE AND DEVELOPMENT POSITIVE HCG POSITIVE

More information

ASSISTED REPRODUCTION TECHNOLOGIES. S. Fernández-Shaw & R. Cercas & C. Braña & C. Villas & I. Pons

ASSISTED REPRODUCTION TECHNOLOGIES. S. Fernández-Shaw & R. Cercas & C. Braña & C. Villas & I. Pons J Assist Reprod Genet (2015) 32:177 184 DOI 10.1007/s10815-014-0387-9 ASSISTED REPRODUCTION TECHNOLOGIES Ongoing and cumulative pregnancy rate after cleavage-stage versus blastocyst-stage embryo transfer

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction Trends in Egg Donation Vitaly A. Kushnir MD Center for Human Reproduction Disclosures No relevant financial relationships to disclose CHR views the commercial trade in human oocytes with considerable ethical

More information

Case Report What Drives Embryo Development? Chromosomal Normality or Mitochondria?

Case Report What Drives Embryo Development? Chromosomal Normality or Mitochondria? Hindawi Case Reports in Genetics Volume 2017, Article ID 4397434, 4 pages https://doi.org/10.1155/2017/4397434 Case Report What Drives Embryo Development? Chromosomal Normality or Mitochondria? A. Bayram,

More information

Day 4 embryo selection is equal to Day 5 using a new embryo scoring system validated in single embryo transfers

Day 4 embryo selection is equal to Day 5 using a new embryo scoring system validated in single embryo transfers Human Reproduction Vol.23, No.7 pp. 1505 1510, 2008 Advance Access publication on February 21, 2008 doi:10.1093/humrep/dem419 Day 4 embryo selection is equal to Day 5 using a new embryo scoring system

More information

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer

More information

Blastocentesis: innovation in embryo biopsy

Blastocentesis: innovation in embryo biopsy Blastocentesis: innovation in embryo biopsy L. Gianaroli, MC Magli, A. Pomante, AP Ferraretti S.I.S.Me.R. Reproductive Medicine Unit, Bologna, Italy Bologna, 8-11 May 2016 www.iiarg.com www.sismer.it 2013

More information

Ultrarapid freezing of early cleavage stage human embryos and eight-cell mouse embryos*

Ultrarapid freezing of early cleavage stage human embryos and eight-cell mouse embryos* FERTILITY AND STERILITY Copyright 1988 The American Fertility Society Printed in U.S.A. Ultrarapid freezing of early cleavage stage human embryos and eight-cell mouse embryos* Alan Trounson, Ph.D.t:!:

More information

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New? Dr Guy Gudex Gynaecologist and Fertility Specialist Repromed 9:05-9:30 Advances in Assisted Reproduction What s New? Rotorua GP CME June 2016 Advances in Assisted Reproduction-What s new? Dr Guy Gudex

More information

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health. Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

Comprehensive chromosome screening and embryo biopsy: advantages and difficulties. Antonio Capalbo, PhD Italy

Comprehensive chromosome screening and embryo biopsy: advantages and difficulties. Antonio Capalbo, PhD Italy Comprehensive chromosome screening and embryo biopsy: advantages and difficulties Antonio Capalbo, PhD Italy Disclosure Antonio Capalbo, PhD GEERA, Reproductive medicine centers GEETYX, molecular genetics

More information

Blastocoele expansion degree predicts live birth after single blastocyst transfer for fresh and vitrified/warmed single blastocyst transfer cycles

Blastocoele expansion degree predicts live birth after single blastocyst transfer for fresh and vitrified/warmed single blastocyst transfer cycles 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 Q6 Q1 ORIGINAL ARTICLE: ASSISTED

More information

World Journal of Pharmaceutical and Life Sciences WJPLS

World Journal of Pharmaceutical and Life Sciences WJPLS wjpls, 2016, Vol. 2, Issue 4, 333-338. Research Article ISSN 2454-2229 WJPLS www.wjpls.org SJIF Impact Factor: 3.347 MORPHOLOGICAL ASSESSMENT OF HUMAN EMBRYOS AND EMBRYO CULTURE USING EMBRYO SCOPE Dr.

More information

Day 4 embryos should not be underestimated in IVF.

Day 4 embryos should not be underestimated in IVF. Research Article http://www.alliedacademies.org/gynecology-reproductive-endocrinology/ Day 4 embryos should not be underestimated in IVF. Noora Kaartinen 1*, Kirsi Kananen 2, Candido Tomás 2, Helena Tinkanen

More information

Preimplantation Genetic Testing

Preimplantation Genetic Testing Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical

More information

The Jones Institute for Reproductive Medicine Founded on Science, Dedicated to Life

The Jones Institute for Reproductive Medicine Founded on Science, Dedicated to Life The Jones Institute for Reproductive Medicine Founded on Science, Dedicated to Life Assisted reproductive technologies: State-of-the-ART Sergio Oehninger, MD, PhD Professor and Vice-Chair, Dept. Ob/Gyn

More information

Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers

Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers Received: 22 October 2017 Accepted: 22 January 2018 DOI: 10.1002/rmb2.12090 ORIGINAL ARTICLE Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers

More information

WHAT IS A PATIENT CARE ADVOCATE?

WHAT IS A PATIENT CARE ADVOCATE? WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Here s Looking at You, Kid: Time Lapse in the Clinical Embryology Laboratory

Here s Looking at You, Kid: Time Lapse in the Clinical Embryology Laboratory Here s Looking at You, Kid: Time Lapse in the Clinical Embryology Laboratory Thomas B. Pool, Ph.D., HCLD Fertility Center of San Antonio San Antonio, Texas Disclosures Speaker, Auxogyn Symposium, ASRM,

More information

Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort

Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort Kato et al. Reproductive Biology and Endocrinology 2012, 10:35 RESEARCH Open Access Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre,

More information

How to make the best use of the natural cycle for frozen-thawed embryo transfer?

How to make the best use of the natural cycle for frozen-thawed embryo transfer? How to make the best use of the natural cycle for frozen-thawed embryo transfer? Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University

More information

Analysis of factors affecting embryo implantation

Analysis of factors affecting embryo implantation Analysis of factors affecting embryo implantation Andrew L.Speirst, H.W.G.Baker and Nusratudin Abdullah The Royal Women's Hospital, Melbourne, Australia ITo whom correspondence should be addressed Introduction

More information

The first human birth from a frozen oocyte

The first human birth from a frozen oocyte FERTILITY Egg freezing is no longer deemed experimental. Here are current protocols, fertility expectations, and safety outcomes as well as ethical considerations for oocyte cryopreservation. Mary E. Abusief,

More information

Cryopreservation of human spermatozoa within human or mouse empty zona pellucidae

Cryopreservation of human spermatozoa within human or mouse empty zona pellucidae FERTILITY AND STERILITY VOL. 73, NO. 4, APRIL 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Cryopreservation of

More information

CONSENT FOR CRYOPRESERVATION OF EMBRYOS

CONSENT FOR CRYOPRESERVATION OF EMBRYOS CONSENT FOR CRYOPRESERVATION OF EMBRYOS We, (Female Partner) and (Partner, Spouse), as participants in the in vitro fertilization (IVF) program at the Reproductive fertility center (REPRODUCTIVE FERTILITY

More information

Closed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles

Closed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles Human Reproduction, Vol.0, No.0 pp. 1 7, 2010 doi:10.1093/humrep/deq338 Hum. Reprod. Advance Access published December 7, 2010 ORIGINAL ARTICLE Embryology Closed blastocyst vitrification of biopsied embryos:

More information

Oocyte zona pellucida dysmorphology is associated with diminished in-vitro fertilization success

Oocyte zona pellucida dysmorphology is associated with diminished in-vitro fertilization success Sauerbrun-Cutler et al. Journal of Ovarian Research (2015) 8:5 DOI 10.1186/s13048-014-0111-5 RESEARCH Open Access Oocyte zona pellucida dysmorphology is associated with diminished in-vitro fertilization

More information

Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study

Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study Human Reproduction, Vol.0, No.0 pp. 1 7, 2012 doi:10.1093/humrep/des088 Hum. Reprod. Advance Access published March 22, 2012 ORIGINAL ARTICLE Embryology Consistent and predictable delivery rates after

More information

INFRAFRONTIER-I3 - Cryopreservation training course. Hosted by the Frozen Embryo and Sperm Archive, MRC - Harwell

INFRAFRONTIER-I3 - Cryopreservation training course. Hosted by the Frozen Embryo and Sperm Archive, MRC - Harwell Hosted by the Frozen Embryo and Sperm Archive, MRC - Harwell IVF recovery procedure incorporting methyl-β-cyclodextrin and reduced glutathione This protocol is based on the work published by Takeo et al.,

More information

Clinical outcomes of vitrified-thawed embryo transfer using a pull and cut straw method

Clinical outcomes of vitrified-thawed embryo transfer using a pull and cut straw method Original Article Obstet Gynecol Sci 2013;56(3):182-189 http://dx.doi.org/10.5468/ogs.2013.56.3.182 pissn 2287-8572 eissn 2287-8580 Clinical outcomes of vitrified-thawed embryo transfer using a pull and

More information

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing

More information

UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS

UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS What is preimplantation genetic testing for aneuploidy? (an abnormal number of chromosomes; PGT-A) is a testing technique that can help choose embryos that appear

More information

Name: Xueming Zhao. Professional Title: Professor. Animal embryo biotechnology, mainly including in vitro maturation (IVM), in vitro fertilization

Name: Xueming Zhao. Professional Title: Professor. Animal embryo biotechnology, mainly including in vitro maturation (IVM), in vitro fertilization Name: Xueming Zhao Professional Title: Professor Telephone:86-010-62815892 Fax:86-010-62895971 E-mail: zhaoxueming@caas.cn Website: http://www.iascaas.net.cn/yjspy/dsjj/sssds/dwyzyzypz1/62040.htm Research

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

CIC Edizioni Internazionali

CIC Edizioni Internazionali Original article Oocyte vitrification/storage/handling/transportation/warming, effect on survival and clinical results in donation programmes Lodovico Parmegiani Antonio Manuel Maccarini Azzurra Rastellini

More information

Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates

Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates What can you put in the Freezer and why would you? Sperm Embryos Eggs Ovarian Tissue Freezing Sperm 60 years ago first human pregnancy

More information

New methods for embryo selection: NGS and MitoGrade

New methods for embryo selection: NGS and MitoGrade New methods for embryo selection: NGS and MitoGrade Santiago Munné, PhD US: Livingston, Los Angeles, Chicago, Portland, Miami / Europe: Barcelona (Spain), Oxford (UK), Hamburg (Germany) / Asia: Kobe (Japan),

More information

Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement

Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement Wei-Hua Wang, Ph.D., Khalied Kaskar, M.S., Yuhong Ren, M.S., Jimmy Gill, M.D.,

More information